You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olanzapine-Fluoxetine Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-Schizophrenic Depression Trial in Bhubaneswar (Amisulpride, Olanzapine-Fluoxetine Combination)

Recruiting
  • Post-Schizophrenic Depression
  • Bhubaneswar, Orissa, India
    All India Institute of Medical Sciences
May 29, 2021

Depression, Sequestra Trial in Chongqing (Fluoxetine, Sertraline, Vortioxetine)

Recruiting
  • Depression
  • Sequestra
  • Chongqing, Province, China
    The First Affiliated Hospital of Chongqing Medical University
Apr 4, 2023

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

SARS-CoV2 Infection, COVID-19 Trial (Combination regimen: Fluoxetine, Prednisolone, Ivermectin, Combination regimen:

Not yet recruiting
  • SARS-CoV2 Infection
  • COVID-19
  • Combination regimen: Fluoxetine, Prednisolone, Ivermectin
  • Combination regimen: Albendazole, Vitamin C
  • (no location specified)
Mar 16, 2022

Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)

Recruiting
  • Olanzapine
  • +3 more
  • Olanzapine Tablets
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Feb 14, 2022

Bipolar Depression, Bipolar Affective Disorder Trial (NRX-101)

Available
  • Bipolar Depression
  • Bipolar Affective Disorder
  • (no location specified)
Mar 22, 2023

Bipolar Disorder Therapies

Completed
  • Bipolar Disorder
  • Lithium Carbonate
  • +29 more
  • Albuquerque, New Mexico
    Christophe G Lambert
Sep 29, 2021

Suicide Crisis Syndrome, Psychological Distress Trial in New York (Clonazepam, Olanzapine, Buprenorphine)

Not yet recruiting
  • Suicide Crisis Syndrome
  • Psychological Distress
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 10, 2023

Depression in Adolescence Trial in Calgary (Pharmacogenetic-guided dosing, GLAD-PC guided dosing)

Not yet recruiting
  • Depression in Adolescence
  • Pharmacogenetic-guided dosing
  • GLAD-PC guided dosing
  • Calgary, Alberta, Canada
    University of Calgary
Jul 25, 2023

Schizophrenia, Bipolar I Disorder Trial in United States (OLZ/SAM, Olanzapine)

Recruiting
  • Schizophrenia
  • Bipolar I Disorder
  • Dothan, Alabama
  • +4 more
Aug 9, 2022

Acute Agitation, Behavioural Emergency Trial in Hong Kong (Olanzapine oro-dispersible 5Mg Tab, Haloperidol 2Mg encapsulated Tab,

Terminated
  • Acute Agitation
  • Behavioural Emergency
  • Olanzapine oro-dispersible 5Mg Tab
  • +2 more
  • Hong Kong, Hong Kong
    Queen Elizabeth Hospital
Nov 3, 2022

Agitation in Adolescents With Autism Spectrum Disorder Trial in Portland, Cincinnati (INP105, Placebo)

Recruiting
  • Agitation in Adolescents and Young Adults With ASD
  • INP105
  • Placebo
  • Portland, Maine
  • +1 more
Oct 21, 2022

Breast Carcinoma Trial in United States (Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride)

Recruiting
  • Breast Carcinoma
  • Honolulu, Hawaii
  • +17 more
May 17, 2022

Postmenopause, Hot Flashes Trial in Mexico City (Fluoxetine 20 MG, Citalopram 20mg)

Completed
  • Postmenopause
  • Hot Flashes
  • Fluoxetine 20 MG
  • Citalopram 20mg
  • Mexico City, Mexico
    Peri-postmenopause and bone metabolism clinic. Regional Hospital
Jul 25, 2022

Schizophrenia Trial in Catonsville (Diet support group, Group counseling and exercise)

Completed
Has Results
  • Schizophrenia
  • Diet support group
  • Group counseling and exercise
  • Catonsville, Maryland
    Maryland Psychiatric Research Center
Mar 1, 2022

Musculoskeletal Injury Trial in Gainesville (Fluoxetine, Placebo)

Not yet recruiting
  • Musculoskeletal Injury
  • Gainesville, Florida
    University of Florida
Sep 18, 2023

Covid19, SARS-Associated Coronavirus Trial in Brazil (Fluvoxamine Maleate 100 MG [Luvox], Budesonide Powder, Placebo (mild

Recruiting
  • Covid19
  • SARS-Associated Coronavirus
  • Fluvoxamine Maleate 100 MG [Luvox]
  • +4 more
  • Betim, MG, Brazil
  • +11 more
Jul 3, 2022

MDD, Bipolar Depression Trial in Boston (Xenon, Nitrogen gas)

Recruiting
  • Major Depressive Disorder
  • Bipolar Depression
  • Boston, Massachusetts
    Dauten Family Center for Bipolar Treatment Innovation
Feb 23, 2022

Post Traumatic Stress Disorder Trial (Intervention A Fluoxetine HCl, Intervention A Placebo)

Not yet recruiting
  • Post Traumatic Stress Disorder
  • Intervention A Fluoxetine HCl
  • Intervention A Placebo
  • (no location specified)
Jul 5, 2023

Borderline Personality Disorder Trial in Chicago (Rexulti, Placebo)

Completed
Has Results
  • Borderline Personality Disorder
  • Chicago, Illinois
    University of Chicago
Mar 16, 2022

OCD, Illness Anxiety Disorder, Body Dysmorphic Disorders Trial in Stanford (Fluoxetine, Dextromethorphan)

Recruiting
  • Obsessive-Compulsive Disorder
  • +3 more
  • Stanford, California
    Stanford University
Mar 15, 2022

Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant , Tropisetron and Olanzapine
  • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
  • Henan, Henan, China
  • +1 more
Apr 11, 2022

Treatment Resistant Depression Trial in China (Olanzapine, Fluoxetine, Placebo)

Terminated
Has Results
  • Treatment Resistant Depression
  • Baoding, China
  • +10 more
Sep 25, 2019

Malignant Tumor Trial in Guam, United States (Palonosetron Hydrochloride, Ondansetron Hydrochloride, Dexamethasone)

Active, not recruiting
  • Malignant Neoplasm
  • Palonosetron Hydrochloride
  • +5 more
  • Birmingham, Alabama
  • +565 more
Jan 6, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Rochester (Olanzapine, Placebo Administration,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023